These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29702134)

  • 1. Threonine 454 phosphorylation in Grainyhead-like 3 is important for its function and regulation by the p38 MAPK pathway.
    Krzywinska E; Zorawski MD; Taracha A; Kotarba G; Kikulska A; Mlacki M; Kwiatkowska K; Wilanowski T
    Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):1002-1011. PubMed ID: 29702134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring GRHL3 polymorphisms and SNP-SNP interactions in the risk of non-syndromic oral clefts in the Brazilian population.
    Azevedo CMS; Machado RA; Martelli-Júnior H; Reis SRA; Persuhn DC; Coletta RD; Rangel ALCA
    Oral Dis; 2020 Jan; 26(1):145-151. PubMed ID: 31564061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated expression and genetic polymorphisms in Grainyhead-like genes in human non-melanoma skin cancers.
    Kikulska A; Rausch T; Krzywinska E; Pawlak M; Wilczynski B; Benes V; Rutkowski P; Wilanowski T
    BMC Cancer; 2018 Jan; 18(1):23. PubMed ID: 29301499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Association between Missense Variants in GRHL3 (rs2486668 and rs545809) and Susceptibility to Non-Syndromic Orofacial Clefts in a Han Chinese Population.
    He M; Bian Z
    PLoS One; 2016; 11(7):e0159940. PubMed ID: 27459192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two rare variants reveal the significance of Grainyhead-like 3 Arginine 391 underlying non-syndromic cleft palate only.
    Huang W; He Q; Li M; Ding Y; Liang W; Li W; Lin J; Zhao H; Chen F
    Oral Dis; 2023 May; 29(4):1632-1643. PubMed ID: 35189007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing the GRHL3 Coding Region Reveals Rare Truncating Mutations and a Common Susceptibility Variant for Nonsyndromic Cleft Palate.
    Mangold E; Böhmer AC; Ishorst N; Hoebel AK; Gültepe P; Schuenke H; Klamt J; Hofmann A; Gölz L; Raff R; Tessmann P; Nowak S; Reutter H; Hemprich A; Kreusch T; Kramer FJ; Braumann B; Reich R; Schmidt G; Jäger A; Reiter R; Brosch S; Stavusis J; Ishida M; Seselgyte R; Moore GE; Nöthen MM; Borck G; Aldhorae KA; Lace B; Stanier P; Knapp M; Ludwig KU
    Am J Hum Genet; 2016 Apr; 98(4):755-62. PubMed ID: 27018475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis.
    Goldie SJ; Cottle DL; Tan FH; Roslan S; Srivastava S; Brady R; Partridge DD; Auden A; Smyth IM; Jane SM; Dworkin S; Darido C
    Cell Death Dis; 2018 Oct; 9(11):1072. PubMed ID: 30341279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel GRHL3 Variants in a South African Cohort With Cleft Lip and Palate.
    Naicker T; Adeleke CC; Alade A; Mossey PA; Awotoye WA; Busch TD; Li M; Olotu J; Gowans LJJ; Aldous C; Butali A
    Cleft Palate Craniofac J; 2022 Sep; 59(9):1125-1130. PubMed ID: 34459660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-Function GRHL3 Variants Detected in African Patients with Isolated Cleft Palate.
    Eshete MA; Liu H; Li M; Adeyemo WL; Gowans LJJ; Mossey PA; Busch T; Deressa W; Donkor P; Olaitan PB; Aregbesola BS; Braimah RO; Oseni GO; Oginni F; Audu R; Onwuamah C; James O; Augustine-Akpan E; Rahman LA; Ogunlewe MO; Arthur FKN; Bello SA; Agbenorku P; Twumasi P; Abate F; Hailu T; Demissie Y; Hailu A; Plange-Rhule G; Obiri-Yeboah S; Dunnwald MM; Gravem PE; Marazita ML; Adeyemo AA; Murray JC; Cornell RA; Butali A
    J Dent Res; 2018 Jan; 97(1):41-48. PubMed ID: 28886269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation by p38 MAP kinase is required for E2F1 degradation and keratinocyte differentiation.
    Ivanova IA; Nakrieko KA; Dagnino L
    Oncogene; 2009 Jan; 28(1):52-62. PubMed ID: 18794805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant mutations in GRHL3 cause Van der Woude Syndrome and disrupt oral periderm development.
    Peyrard-Janvid M; Leslie EJ; Kousa YA; Smith TL; Dunnwald M; Magnusson M; Lentz BA; Unneberg P; Fransson I; Koillinen HK; Rautio J; Pegelow M; Karsten A; Basel-Vanagaite L; Gordon W; Andersen B; Svensson T; Murray JC; Cornell RA; Kere J; Schutte BC
    Am J Hum Genet; 2014 Jan; 94(1):23-32. PubMed ID: 24360809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase.
    Mikkola I; Bruun JA; Bjorkoy G; Holm T; Johansen T
    J Biol Chem; 1999 May; 274(21):15115-26. PubMed ID: 10329718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis of SNPs in GRHL3, FAF1, and KCNJ2 with NSCPO sub-phenotypes in Han Chinese.
    Sun JL; Shi JY; Yin B; Lin YS; Shi B; Jia ZL
    Oral Dis; 2022 Nov; 28(8):2204-2214. PubMed ID: 34255421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRHL3 activates FSCN1 to relax cell-cell adhesions between migrating keratinocytes during wound reepithelialization.
    Kashgari G; Venkatesh S; Refuerzo S; Pham B; Bayat A; Klein RH; Ramos R; Ta AP; Plikus MV; Wang PH; Andersen B
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34494554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1.
    Bhandari A; Gordon W; Dizon D; Hopkin AS; Gordon E; Yu Z; Andersen B
    Oncogene; 2013 Mar; 32(12):1497-507. PubMed ID: 22614019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of
    Mathiyalagan N; Miles LB; Anderson PJ; Wilanowski T; Grills BL; McDonald SJ; Keightley MC; Charzynska A; Dabrowski M; Dworkin S
    Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31683705
    [No Abstract]   [Full Text] [Related]  

  • 17. A Genome-wide Association Study of Nonsyndromic Cleft Palate Identifies an Etiologic Missense Variant in GRHL3.
    Leslie EJ; Liu H; Carlson JC; Shaffer JR; Feingold E; Wehby G; Laurie CA; Jain D; Laurie CC; Doheny KF; McHenry T; Resick J; Sanchez C; Jacobs J; Emanuele B; Vieira AR; Neiswanger K; Standley J; Czeizel AE; Deleyiannis F; Christensen K; Munger RG; Lie RT; Wilcox A; Romitti PA; Field LL; Padilla CD; Cutiongco-de la Paz EM; Lidral AC; Valencia-Ramirez LC; Lopez-Palacio AM; Valencia DR; Arcos-Burgos M; Castilla EE; Mereb JC; Poletta FA; Orioli IM; Carvalho FM; Hecht JT; Blanton SH; Buxó CJ; Butali A; Mossey PA; Adeyemo WL; James O; Braimah RO; Aregbesola BS; Eshete MA; Deribew M; Koruyucu M; Seymen F; Ma L; de Salamanca JE; Weinberg SM; Moreno L; Cornell RA; Murray JC; Marazita ML
    Am J Hum Genet; 2016 Apr; 98(4):744-54. PubMed ID: 27018472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grainyhead-like Transcription Factors in Craniofacial Development.
    Carpinelli MR; de Vries ME; Jane SM; Dworkin S
    J Dent Res; 2017 Oct; 96(11):1200-1209. PubMed ID: 28697314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent discoveries concerning the involvement of transcription factors from the Grainyhead-like family in cancer.
    Mlacki M; Kikulska A; Krzywinska E; Pawlak M; Wilanowski T
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1396-401. PubMed ID: 26069269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 6 promotes differentiation of the periderm by activating expression of Grainyhead-like 3.
    de la Garza G; Schleiffarth JR; Dunnwald M; Mankad A; Weirather JL; Bonde G; Butcher S; Mansour TA; Kousa YA; Fukazawa CF; Houston DW; Manak JR; Schutte BC; Wagner DS; Cornell RA
    J Invest Dermatol; 2013 Jan; 133(1):68-77. PubMed ID: 22931925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.